December 23, 2020 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …
December 23, 2020 Comments Off on New tentative approval for Breckenridge drug asenapine maleate Posted in: Tentative Approval Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
The post New tentative approval for Breckenridge drug asenapi…